Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study.
about
Low Dose Total Body Irradiation Combined With Recombinant CD19-Ligand × Soluble TRAIL Fusion Protein is Highly Effective Against Radiation-Resistant B-Precursor Acute Lymphoblastic Leukemia in MiceGene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.Outcomes of Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults with Chronic Myeloid Leukemia: A CIBMTR Cohort AnalysisA Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies.A Practical Approach to the Diagnosis and Management of Hair Loss in Children and Adolescents.Adverse health events and late mortality after pediatric allogeneic hematopoietic SCT-two decades of longitudinal follow-up.Comparison of two cytoreductive regimens for αβ-T-cell-depleted haploidentical HSCT in pediatric malignancies: Improved engraftment and outcome with TBI-based regimen.Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters.Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation.Late effects after hematopoietic stem cell transplantation for β-thalassemia major: the French national experience.
P2860
Q35747708-7B7799AD-93E6-4639-A76E-83AF895E3DD4Q36654528-05DBE640-373A-4041-B6AB-5FD32DE03377Q36928803-4942D2A0-6738-469B-B03D-183AC6AE9315Q40121414-4BFC274A-D25E-42C1-80A0-911F736B48E7Q41097430-CA732EAB-7CD9-4231-87F8-14E1F89F3BE4Q41179462-32C2A237-8622-4456-BC27-5E97C25FCA18Q47681511-E8D5718E-5099-4AF1-8F22-04BCDDB7C203Q47959792-CCFB4E93-5DB2-4AF3-AEA9-A591BC441F3EQ48596388-05F42986-7CD9-4280-A71F-592F6FD1DFC0Q52690736-398643E6-E18D-448E-8E83-25EA486C1BF2Q55638215-DC5B192B-1B84-4105-B3E9-D22B646FF2B2
P2860
Health status of childhood leukemia survivors who received hematopoietic cell transplantation after BU or TBI: an LEA study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Health status of childhood leu ...... after BU or TBI: an LEA study.
@en
Health status of childhood leu ...... after BU or TBI: an LEA study.
@nl
type
label
Health status of childhood leu ...... after BU or TBI: an LEA study.
@en
Health status of childhood leu ...... after BU or TBI: an LEA study.
@nl
prefLabel
Health status of childhood leu ...... after BU or TBI: an LEA study.
@en
Health status of childhood leu ...... after BU or TBI: an LEA study.
@nl
P2093
P2860
P356
P1476
Health status of childhood leu ...... after BU or TBI: an LEA study.
@en
P2093
C Galambrun
H Chambost
I Herrmann
P2860
P2888
P304
P356
10.1038/BMT.2014.3
P407
P577
2014-02-17T00:00:00Z